Baldness treatment co gets $5.5m:
This article was originally published in Clinica
Executive Summary
Follica, a Boston, Massachusetts firm developing a technology for treating hair loss caused by androgens in genetically susceptible men and women, has closed a $5.5m Series A financing round. The fundraising was led by Interwest Partners, and included the participation of existing investor PureTech Ventures participated. The new capital will take the company through a clinical proof-of-concept study. Follica's technology is designed to create and manipulate hair follicles in sufferers of androgenetic alopecia, a condition that affect around 50% of men and women in the US by the age of 50. The company said its technology can also be developed for treating other hair loss conditions and follicle-related disorders such as acne.